Hu Bowen, Wang Linnan, Song Yueming, Hu Yujie, Lyu Qiunan, Liu Limin, Zhu Ce, Zhou Chunguang, Yang Xi
Department of Orthopedics Surgery, West China Hospital, Sichuan University, No. 37 GuoXue Road, Chengdu, Sichuan, 610041, China.
Department of Orthopedics Surgery, West China Hospital, Sichuan University, No. 37 GuoXue Road, Chengdu, Sichuan, 610041, China.
Clin Neurol Neurosurg. 2019 Jan;176:25-29. doi: 10.1016/j.clineuro.2018.11.015. Epub 2018 Nov 19.
The nanohydroxyapatite/polyamide-66 (n-HA/PA66) cage is a novel biomimetic nonmetal cage device that is now used in some medical centers, while the titanium mesh cage (TMC) is a typical metal cage device that has been widely used for decades. This study was performed to compare the long-term outcomes of these two different cages in patients undergoing anterior cervical corpectomy.
This retrospective study involved 107 patients who underwent single-level anterior corpectomy using either a TMC (n = 52) or an n-HA/PA66 cage (n = 55) for treatment of cervical degenerative disease with a minimum follow-up of 8 years. Their radiographic data (cage subsidence, fusion status, segmental sagittal alignment, and cervical spine degeneration) and clinical data [visual analog scale (VAS) and Japanese Orthopedic Association (JOA) scores] were evaluated preoperatively, postoperatively, and at the final follow-up.
The mean duration of follow-up was 103.6 ± 6.3 months in the n-HA/PA66 group and 102.4 ± 4.6 months in the TMC group. The n-HA/PA66 group and the TMC group had similar final fusion rates (97% vs. 94%, respectively). The final n-HA/PA66 cage subsidence was 2.4 ± 1.0 mm with 18.2% subsidence of >3 mm, which was significantly lower than the respective 3.0 ± 0.7 mm and 40.4% for the TMC (p < 0.01). The n-HA/PA66 group also had better JOA scores than the TMC group (p < 0.01). No significant difference in the segmental sagittal alignment, cervical lordosis, or VAS score was observed between the two groups (p = 0.18, 0.42, and 0.17, respectively).
The n-HA/PA66 cage is associated with excellent radiographic fusion, lower subsidence and better clinical outcomes than the TMC within 8 years after single-level anterior cervical corpectomy. With the addtional benefit of radiolucency, the n-HA/PA66 cage could be superior to the TMC in anterior cervical construction.
纳米羟基磷灰石/聚酰胺-66(n-HA/PA66)椎间融合器是一种新型的仿生非金属椎间融合器装置,目前已在一些医疗中心使用,而钛网椎间融合器(TMC)是一种典型的金属椎间融合器装置,已广泛使用数十年。本研究旨在比较这两种不同椎间融合器在接受颈椎前路椎体次全切除患者中的长期疗效。
本回顾性研究纳入了107例行单节段颈椎前路椎体次全切除的患者,其中52例使用TMC,55例使用n-HA/PA66椎间融合器,用于治疗颈椎退行性疾病,随访时间至少8年。对他们术前、术后及末次随访时的影像学数据(椎间融合器下沉、融合状态、节段矢状位对线及颈椎退变情况)和临床数据[视觉模拟评分(VAS)及日本骨科协会(JOA)评分]进行评估。
n-HA/PA66组平均随访时间为103.6±6.3个月,TMC组为102.4±4.6个月。n-HA/PA66组和TMC组的最终融合率相似(分别为97%和94%)。n-HA/PA66椎间融合器最终下沉2.4±1.0mm,下沉>3mm的比例为18.2%,显著低于TMC组的3.0±0.7mm和40.4%(p<0.01)。n-HA/PA66组的JOA评分也优于TMC组(p<0.01)。两组间节段矢状位对线、颈椎前凸或VAS评分无显著差异(分别为p=0.18、0.42和0.17)。
在单节段颈椎前路椎体次全切除术后8年内,n-HA/PA66椎间融合器与TMC相比,具有良好的影像学融合效果、更低的下沉率及更好的临床疗效。鉴于n-HA/PA66椎间融合器具有透X线的额外优势,在颈椎前路手术中可能优于TMC。